Elanco EVP granted 61 deferred stock units

Q: What insider transaction did ELAN report for Rajeev A. Modi on this Form 4?

Elanco Animal Health Inc reported that Rajeev A. Modi received a grant of 61.6158 Deferred Stock Units on 2026-08-21 as a compensation-related award, classified as an acquisition transaction.

Q: How many Elanco (ELAN) Deferred Stock Units does Rajeev A. Modi hold after this transaction?

After the reported award, Rajeev A. Modi holds a total of 9,770.3122 Deferred Stock Units of Elanco Animal Health Inc, reported as direct ownership.

Q: What does each Deferred Stock Unit represent for Elanco (ELAN)?

Each Elanco Deferred Stock Unit represents the right to receive one share of Elanco common stock or the cash equivalent, according to the footnote describing the award.

Q: When will the Elanco (ELAN) Deferred Stock Units granted to Rajeev A. Modi settle?

The Deferred Stock Units will settle in cash or shares of Elanco common stock following termination of employment or during a specified future year, in accordance with the company’s Executive Deferral and Stock Match Plan.

Q: Was the Elanco (ELAN) Form 4 transaction under a Rule 10b5-1 trading plan?

No. The filing indicates the Rule 10b5-1 checkbox is not checked (aff_10b5_one is false), and there is no footnote stating that the transaction was executed under a 10b5-1 trading plan.

Q: What was the reported value per Deferred Stock Unit in the Elanco (ELAN) grant?

The award to Rajeev A. Modi reported a transaction price of $23.9700 per Deferred Stock Unit, with 61.6158 units granted on 2026-08-21.

Elanco Animal Health Inc (ELAN) reported that Executive Vice President U.S. Pet Health and Global Digital Transformation Rajeev A. Modi acquired 61.6158 Deferred Stock Units on 2026-08-21 as a grant or award.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Elanco Animal Health Inc (ELAN) reported that Executive Vice President U.S. Pet Health and Global Digital Transformation Rajeev A. Modi acquired 61.6158 Deferred Stock Units on 2026-08-21 as a grant or award. Each unit corresponds to one share of common stock or the cash equivalent and will settle in cash or shares after employment ends or in a specified future year under the Executive Deferral and Stock Match Plan. Following this award, Modi holds a total of 9,770.3122 Deferred Stock Units directly.

Insider Trade Summary

Grant/Award: 61.6158 shares

Grant/Award 1 txn

Insider Modi Rajeev A.

Role SEE REMARKS

Type	Security	Shares	Price	Value
Grant/Award	Deferred Stock Units ^{F1, F2}	61.6158	$23.97	$1K

Holdings After Transaction: Deferred Stock Units — 9,770.3122 contracts (Direct)

Footnotes (2)

F1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
F2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

Key Figures

Deferred Stock Units granted: 61.6158 units Transaction price per Deferred Stock Unit: $23.9700 per unit Deferred Stock Units held after transaction: 9,770.3122 units +1 more

4 metrics

Deferred Stock Units granted 61.6158 units Grant/award acquisition on 2026-08-21

Transaction price per Deferred Stock Unit $23.9700 per unit Price associated with the 61.6158-unit grant on 2026-08-21

Deferred Stock Units held after transaction 9,770.3122 units Total direct holdings of Deferred Stock Units by Rajeev A. Modi after the award

Underlying common stock per unit 1 share per unit Each Deferred Stock Unit represents the right to receive one share of common stock or cash equivalent

Key Terms

Deferred Stock Units, Executive Deferral and Stock Match Plan, cash equivalent

3 terms

Deferred Stock Units financial

"Each deferred stock unit represents the right to receive one share of Company"

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

Executive Deferral and Stock Match Plan financial

"in accordance with Executive Deferral and Stock Match Plan."

cash equivalent financial

"one share of Company common stock or the cash equivalent."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did ELAN report for Rajeev A. Modi on this Form 4?

Elanco Animal Health Inc reported that Rajeev A. Modi received a grant of 61.6158 Deferred Stock Units on 2026-08-21 as a compensation-related award, classified as an acquisition transaction.

How many Elanco (ELAN) Deferred Stock Units does Rajeev A. Modi hold after this transaction?

After the reported award, Rajeev A. Modi holds a total of 9,770.3122 Deferred Stock Units of Elanco Animal Health Inc, reported as direct ownership.

What does each Deferred Stock Unit represent for Elanco (ELAN)?

Each Elanco Deferred Stock Unit represents the right to receive one share of Elanco common stock or the cash equivalent, according to the footnote describing the award.

When will the Elanco (ELAN) Deferred Stock Units granted to Rajeev A. Modi settle?

The Deferred Stock Units will settle in cash or shares of Elanco common stock following termination of employment or during a specified future year, in accordance with the company’s Executive Deferral and Stock Match Plan.

Was the Elanco (ELAN) Form 4 transaction under a Rule 10b5-1 trading plan?

No. The filing indicates the Rule 10b5-1 checkbox is not checked (aff_10b5_one is false), and there is no footnote stating that the transaction was executed under a 10b5-1 trading plan.

What was the reported value per Deferred Stock Unit in the Elanco (ELAN) grant?

The award to Rajeev A. Modi reported a transaction price of $23.9700 per Deferred Stock Unit, with 61.6158 units granted on 2026-08-21.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 08/25/2026 - 04:43 PM EDT Accepted by SEC EDGAR 08/25/2026 - 04:42 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Modi Rajeev A.

(Last)

(First)

(Middle)

C/O ELANCO ANIMAL HEALTH INCORPORATED

450 ELANCO CIRCLE

(Street)

INDIANAPOLIS

INDIANA

46221

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SEE REMARKS

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Deferred Stock Units	⁽¹⁾	08/21/2026		A		61.6158		⁽²⁾	⁽²⁾	Common Stock	61.6158	$23.97	9,770.3122	D

Explanation of Responses:

1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.

2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

Remarks:

Executive Vice President U.S. Pet Health and Global Digital Transformation

	/s/ Amy C. Seidel, as Attorney-in-Fact for Rajeev A. Modi	08/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR